Topics

Companies Related to "Evolution Approval Regulation Processes Drugs Explored" [Most Relevant Company Matches] [Search Results] RSS

11:50 EDT 2nd April 2020 | BioPortfolio

Here are the most relevant search results for "Evolution Approval Regulation Processes Drugs Explored" found in our extensive corporate database of over 50,000 company records.

Showing "Evolution Approval Regulation Processes Drugs Explored" Companies 1–25 of 3,100+

Relevant

FormFast

Since 1992, FormFast has been passionate about delivering high-value document automation and management systems to healthcare providers. Their technology supports the progression from time-consuming processes of filling, managing, and processing forms manually to the increased efficiency of an output management system. This evolution is supported with the ...


Carmot Therapeutics

Carmot is pioneering a transformative drug discovery approach, Chemotype Evolution, to identify superior therapeutics for human diseases. Chemotype Evolution is a proprietary technology that dramatically expands the repertoire of chemical diversity for drug discovery, providing the opportunity to tackle therapeutic targets refractory to traditional approac...

Novasite Pharmaceuticals, Inc

Novasite is a drug discovery company using structure-function relationships in validated G protein coupled receptor targets to find better GPCR modulating drugs.Novasite began as a majority-owned subsidiary of Applied Molecular Evolution, Inc. (“AME”), which was acquired by Eli Lilly in 2004 for $400M. Novasite is the exclusive licensee of AME molecular evolution technology, which the Company ...


Texas State Board of Pharmacy

To promote, preserve, and protect the public health, safety, and welfare by fostering the provision of quality pharmaceutical care to the citizens of Texas through the regulation of the practice of pharmacy, the operation of pharmacies, and the distribution of prescription drugs in the public interest.The Texas State Board of Pharmacy will assume a leadership role in regulating the practice of pha...

BioDelivery Sciences International

We are a specialty pharmaceutical company that is exploiting its licensed and proprietary patented drug delivery technologies to develop and commercialize, either on our own or in partnerships with third parties, clinically-significant new formulations of proven therapeutics. Our development strategy focuses on the utilization of the FDA’s 505(b)(2) approval process to obtain more timely and eff...

Celltrion Inc.

Headquartered in Incheon, Korea, Celltrion is a leading biopharmaceutical company, specializing in research, development and manufacture of biosimilar and innovative drugs. Celltrion strives to provide more affordable biosimilar mAbs to patients who previously had limited access to advanced therapeutics. Celltrion received FDA and EMA approval for Inflectr...

Keane Inc.

Keane partners with businesses and government agencies to optimize IT investments by delivering exceptional operation, maintenance, and evolution of mission-critical systems and business processes. Keane helps clients realize the greatest value from their IT investments by leveraging an insider's hands-on understanding of the nuances and subtleties of their applications, processes and infrastruct...

Addrenex Pharmaceuticals, Inc.

Addrenex Pharmaceuticals is a focused, specialty pharmaceutical company that develops and commercializes drugs to treat adrenergic dysregulation. Addrenex Pharmaceuticals is based in Durham, N.C., on the edge of Research Triangle Park. The company's mission is to explore the impact that neurotransmitter regulation has on a variety of diseases and disorders. Addrenex identified adrenergic regulatio...

Association of Diabetes Investigator's

We work together with the pharmaceutical industry to develop agents to improve the lives of diabetic patients. It is in our joint interest to identify promising areas for drug development and to streamline the processes leading to approval and marketing of new agents. As the lead investigators in numerous studies which have brought new drugs into common use, we have acquired a unique experie...

Leader Ventures

Carmot Therapeutics was founded by Drs. Hansen and Erlanson in 2008 with the goal of commercializing and further developing Chemotype Evolution. Carmot has licensed the technology and fragment libraries from Sunesis, and Carmot is in the process of further expanding the capabilities of Chemotype Evolution. Chemotype Evolution is a patent pending technology that was invented by Drs. Stig K. Hansen ...

Kronos Communicated Data Inc.

Formed in 1993 to take advantage of the technical advancements and business evolution brought about by emerging technologies, Kronos builds solutions solely for pharmaceutical and biotech research. Integrating expertise in software development and communications has resulted in the delivery of the newest interactive data collection, analysis and dissemination.Today's challenge is to use technology...

Northwest Bioanalytical

Specialize in the application of advanced mass spectrometric techniques for identification and precise measurement of drugs and related substances in biological specimens. Our staff brings the required expertise in mass spectrometry to developing and applying assays with the sensitivity and specificity pharmaceutical companies depend on as new drugs move along the challenging path to FDA approval.

Carmot Therapeutics, Inc.

Carmot Therapeutics, Inc. is pioneering a transformative lead-identification technology, Chemotype Evolution, to identify superior therapeutics for human diseases. The technology provides rapid access to novel, target-relevant chemical diversity, thereby addressing important unmet chemical needs. Moreover, Chemotype Evolution can identify small molecules w...

Madeira Therapeutics, LLC

Madeira Therapeutics, LLC, is a privately held, specialty pharmaceutical company focused on providing safe and effective medicine to pediatric and geriatric patients, parents and the healthcare professionals who serve them. The Madeira strategy focuses on reformulating adult drugs for better dosage control in children. Madeira utilizes the FDA’s 505(b...

Cytel Inc

Science is on the brink of profound new discoveries in medicine and biotechnology. At no time in history has the promise of new drugs and breakthrough treatments for human suffering been greater than it is today. And never have the stakes been higher. At the same time, the pharmaceutical and biotech industries are under increased public and private scrutiny for the processes by which new treatment...

Lorantis

Lorantis is discovering and developing breakthrough products for the selective treatment of immunological and inflammatory diseases based on immune regulation: the induction of antigen-specific tolerance. Current therapies for immunological and inflammatory diseases either relieve only the symptoms or induce non-specific suppression of the immune system. This can lead to severe infection and drug-...

Pharmaceutical Special Projects Group, LLC

Pharmaceutical Special Projects Group, LLC At PSPG we’re serious about the drug approval process. Not all drugs are approvable, but if yours is, you can be sure that we will move heaven and earth to give it the best and quickest route through the regulatory approval process. We have many years of experience SUCCESSFULLY getting drugs approved by regulators all over the world. We have never ha...

Nextera Communications

Nextera is a privately owned Norwegian biotech company. Our approach is to manipulate the disease at the initiation of the escalating immune cascade by identifying and subsequently targeting the principal causative agent. The core technology of the company is our phage display engine, which we apply in protein engineering and evolution of T cell receptors ...

DIVURGENT

Divurgent is not the typical healthcare consulting firm. As a nationally recognized company, we are committed to healthcare evolution and the strategies and processes that make it possible. We help our clients evolve in payment and delivery reform, as well as patient engagement, providing higher quality of care, lower cost of care, and healthier communitie...

Message Pharmaceuticals Incorporated

MESSAGE PHARMACEUTICALS, INC. is an emerging biotechnology company dedicated to developing novel and proprietary screening assays for discovering new drugs. Currently, most drugs act by binding to specific sequences and structures within a target protein, such as a receptor or enzyme, and altering the protein's activity or function. MESSAGE's technology will allow for the identification of drugs...

AGBIOS

AGBIOS is a Canadian company dedicated to providing public policy, regulatory, and risk assessment expertise for products of biotechnology. AGBIOS has worked with federal departments and agencies on issues of policy and regulation pertaining to genetically modified and other novel foods, crops, and forest tree species. The Company also provides experience and expertise to commercial enterprises se...

EUCODIS GmbH

EUCODIS is a biotechnology company successfully generating novel products in the life science area by successfully applying two most powerful technologies mimicking natural processes of evolution, in vivo recombination and somatic hypermutation. EUCODIS current activities are focused on projects and products in field of industrial enzymes and strain optimization as well as generation of novel biop...

GENEART AG

GENEART provides integrated system solutions for DNA engineering and processing based on the gene synthesis technology platform to deliver improved drugs and biotech products. The services portfolio ranges from the production of optimized synthetic genes and the generation of gene variants and gene libraries in combinatorial biology (gene evolution) right through to the production of DNA-based age...

ILEX Oncology Incorporated

ILEX Oncology, Inc. is a drug development company focused exclusively on accelerated development of drugs for thetreatment and prevention of cancer. The Company uses its expertise in the identification, development, manufacturing and regulatory approval process of oncology drugs to (i) develop cancer treatment products, (ii) develop products for the prevention of cancer and (iii) provide contract ...

Selexis SA and OSE Immunotherapeutics SA

Our ambition is to become a world leader in activation and regulation immunotherapies: OSE Immunotherapeutics is a biotechnology company led by world-class immunologists and focused on the development of innovative immunotherapies of activation and regulation in immuno-oncology, autoimmune diseases and transplantation. The company has a balanced portfolio ...


More From BioPortfolio on "Evolution Approval Regulation Processes Drugs Explored"

Quick Search

Corporate Database Quicklinks